PLEASE REVIEW OUR PRIVACY & COOKIES NOTICE

We use cookies to collect and analyze information on site performance and usage and to ensure you can successfully navigate throughout the site.   By clicking the “ACCEPT” button to your right or by clicking on any site content, you agree to the placement of cookies on your computer.  For more information, see our Privacy Policy. 

Locations
 
WEBSITES
  • United States (English)
  • International (English)
  • Chinese (中文)
  • French (Français)
  • German (Deutsch)
  • Italian (Italiano)
  • Japanese (日本語)
  • Russian (Русский)
  • Whole Blood Technologies
 

Leaving U.S. website

You are now leaving the Haemonetics U.S. website, click 'Yes' to continue or 'No' to stay on the U.S. website.

YesNo
  • Investor Relations
  • LOGIN
    • Haemonetics
    • HSS Client Login
    • Software Download Center
  • REGISTER
  • Home
  • Products
     
    Whole Blood TechnologiesView Other Products
    Collection and Processing
    • Acrodose­ PL & PLus Systems
    • DATA-5 Software
    • eBDS System
    • Leukotrap WB with SAVE System
    • Transfer Bag for Cryo Pooling
    • Whole Blood Collection and Component Storage Systems
    Filtration and Transfusion
    • Leukoreduction Filter Sets
    • Microaggregate Blood Transfusion Filter
    • Salvaged Blood Filters
    Blood Management Solutions
    • Blood Center Products
    • Hospital Products
    • Plasma Center Products
     
  • Solutions
     
    Whole Blood Technologies
    • Collection Technologies
    • Processing Technologies
    • Filtration & Transfusion Technologies
    Blood Management Solutions
    • Solutions for Blood Centers
    • Solutions for Hospitals
    • Solutions for Plasma Centers
    • Software Solutions
    • Donor Process Automation
     
  • Learning Center
     
    Thought Leadership
    • White Papers & Clinical Reviews
    • Poster Abstracts
    Education
    • Presentations
     
  • About Haemonetics
     
    Company Background
    • Overview
    • Historical Timeline
    • Leadership Team
    • Leadership Team
    • <p>Scientific Advisory Council</p>
    • <p>Scientific Advisory Council</p>
    • Office Locations
    Investor Relations
    • Investor Relations Home
    • Stock Information
    • Earnings
    • Forecasts & Guidance
    News &amp; Events
    • In the News
    • Calendar of Events
    • Publications
    Careers
    • Careers Overview
    • Employee Spotlights
    • Open Positions
    <p>Grants</p>
       
    • Customer Support
    • Home
    • Learning Center
    • Thought Leadership
    • White Papers & Clinical Reviews
    • Contact Us
    • Print
    • Share

    White Papers & Clinical Reviews

    • FOCUS Trial
    • FOCUS Trial - Functional outcomes in cardiovascular patients undergoing surgical repair of hip fracture

      Clinical Review: N Engl J Med 2011; 365:2453-62

      Conclusion: A liberal transfusion strategy, as compared with a restrictive strategy, did not reduce rates of death or inability to walk independently on 60-day follow-up or reduce in-hospital morbidity in elderly patients at high cardiovascular risk.
      View document
    • Anemia and the Perioperative Patient

      White Paper by M. Popovsky, M.D., R. Thurer, M.D., P. Parce, RN

      Excerpt: Anemia is a remarkably prevalent condition. Forty percent of patients presenting with hip fracture and 38% of acutely admitted geriatric patients have anemia (5). Studies of critically ill patients found that 77% experience anemia in the ICU. Sixty three percent of these patients had hemoglobin values less than 12 g/dL and 29% less than 10g/dL. View document View reference list
    • Blood Management: State of the Art
      The Use of Red Blood Cells and Fresh Frozen Plasma

      White Paper by M. Popovsky, M.D., R. Thurer, M.D., P. Parce, RN

      Excerpt: Blood transfusion is an integral part of medical and surgical practice, and its safety is now assumed. Although the transmission of virus-borne diseases – such as HIV and hepatitis – by blood transfusion are extraordinarily rare events, blood should be viewed as a potent drug that entails significant risk.
      View document View reference list
    • The Pros and Cons of Preoperative Autologous Blood Donation

      White Paper by Mark A. Popovsky, M.D., Robert L. Thurer, M.D.

      Preoperative autologous blood donation (PABD) was once a powerful tool to decrease the risk of transfusion-transmitted disease related to allogeneic blood. With the development of effective viral screening tests and the recognition of the many disadvantages of stored blood, the need for and appropriateness of PABD has greatly diminished. There are now better and safer alternatives. The advantages and disadvantages of PABD are discussed in this review. View document
    • Contact Us
    • Terms of Use
    • Quality
    • Careers
    • Privacy Policy
    • Site Map

    © 2011-2019 Haemonetics Corporation